In response to a request from employees at a casino in Atlantic City, New Jersey, NIOSH performed a field study to evaluate the exposure of gaming floor workers to environmental tobacco smoke (ETS) using both environmental and biologic measures of exposure. Vapor phase nicotine (54115) and respirable particulate were monitored as marker substances for exposure to ETS. Eighteen personal breathing zone (PBZ) samples for nicotine and ten area samples each for nicotine vapor and respirable dust were collected. PBZ nicotine exposures for the Thursday evening monitoring ranged from 6 to 12 micrograms/cubic meter (microg/m3). The highest PBZ sample was from a dealer working a poker game, 12 microg/m3. Twenty nine (10%) of the dealers and supervisors at work during the study participated. None reported current personal tobacco use. Seventeen reported no exposure to ETS outside the workplace. Positive, but nonsignificant, correlations were noted between PBZ air nicotine concentration and both post shift serum cotinine (486566) and cross shift changes in serum cotinine. The duration of ETS exposure reported in the questionnaires was not significantly correlated with serum or urine cotinine concentrations. Working at nonsmoking tables did not measurably decrease employee exposure to ETS. Until tobacco use can be completely eliminated, employers should make efforts to protect employees from ETS by isolating areas where smoking is permitted. Separate smoking areas with dedicated ventilation are a means to accomplish this. Restricting smoking to the outdoors is another method.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.